Celularity (United States)
Celularity’s innovative approach harnesses the unique therapeutic potential locked within the cells and biomaterials of the postpartum placenta. We have multiple cell therapy candidates in active clinical development as well as a broad range of placental-derived biomaterial products for therapeutic use. The Next Evolution In Cellular Medicine At Celularity, we believe that by harnessing the placenta’s unique biology, ready availability and scalability, we can develop solutions for significant un
Basic Information
- Category: business
- Website: https://celularity.com/
Documented Facts
- Phone: 593-179.0735 (No linked source recorded for this statement.)
Evidence and Sources
- Celularity (United States) — Official Site (official)
- Celularity (United States) on instagram (social)
- Celularity (United States) on linkedin (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Celularity (United States).
- Canonical profile: https://brandsource.ai/brands/celularity-united-states
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/celularity-united-states/json-ld
- Citation profile API: https://brandsource.ai/api/brands/celularity-united-states/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (85/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Celularity’s innovative approach harnesses the unique therapeutic potential locked within the cells and biomaterials of the postpartum placenta. We have multiple cell therapy candidates in active clinical development as well as a broad range of placental-derived biomaterial products for therapeutic use. The Next Evolution In Cellular Medicine At Celularity, we believe that by harnessing the placenta’s unique biology, ready availability and scalability, we can develop solutions for significant un
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.